284 related articles for article (PubMed ID: 32620010)
1. Pregnancy Per- and Polyfluoroalkyl Substance Concentrations and Postpartum Health in Project Viva: A Prospective Cohort.
Mitro SD; Sagiv SK; Fleisch AF; Jaacks LM; Williams PL; Rifas-Shiman SL; Calafat AM; Hivert MF; Oken E; James-Todd TM
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3415-26. PubMed ID: 32620010
[TBL] [Abstract][Full Text] [Related]
2. Per- and Polyfluoroalkyl Substances and Hormone Levels During the Menopausal Transition.
Harlow SD; Hood MM; Ding N; Mukherjee B; Calafat AM; Randolph JF; Gold EB; Park SK
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4427-e4437. PubMed ID: 34181018
[TBL] [Abstract][Full Text] [Related]
3. Per- and Polyfluoroalkyl Substance Plasma Concentrations and Bone Mineral Density in Midchildhood: A Cross-Sectional Study (Project Viva, United States).
Cluett R; Seshasayee SM; Rokoff LB; Rifas-Shiman SL; Ye X; Calafat AM; Gold DR; Coull B; Gordon CM; Rosen CJ; Oken E; Sagiv SK; Fleisch AF
Environ Health Perspect; 2019 Aug; 127(8):87006. PubMed ID: 31433236
[TBL] [Abstract][Full Text] [Related]
4. Per- and Polyfluoroalkyl Substance Exposure, Gestational Weight Gain, and Postpartum Weight Changes in Project Viva.
Mitro SD; Sagiv SK; Rifas-Shiman SL; Calafat AM; Fleisch AF; Jaacks LM; Williams PL; Oken E; James-Todd TM
Obesity (Silver Spring); 2020 Oct; 28(10):1984-1992. PubMed ID: 32959518
[TBL] [Abstract][Full Text] [Related]
5. Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women.
Ding N; Karvonen-Gutierrez CA; Herman WH; Calafat AM; Mukherjee B; Park SK
Int J Hyg Environ Health; 2021 Jun; 235():113777. PubMed ID: 34090141
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva.
Rokoff LB; Wallenborn JT; Harris MH; Rifas-Shiman SL; Criswell R; Romano ME; Young JG; Calafat AM; Oken E; Sagiv SK; Fleisch AF
Sci Total Environ; 2023 Sep; 891():164724. PubMed ID: 37290653
[TBL] [Abstract][Full Text] [Related]
7. Sociodemographic and Perinatal Predictors of Early Pregnancy Per- and Polyfluoroalkyl Substance (PFAS) Concentrations.
Sagiv SK; Rifas-Shiman SL; Webster TF; Mora AM; Harris MH; Calafat AM; Ye X; Gillman MW; Oken E
Environ Sci Technol; 2015 Oct; 49(19):11849-58. PubMed ID: 26333069
[TBL] [Abstract][Full Text] [Related]
8. Associations of Prenatal Per- and Polyfluoroalkyl Substance (PFAS) Exposures with Offspring Adiposity and Body Composition at 16-20 Years of Age: Project Viva.
Zhang M; Rifas-Shiman SL; Aris IM; Fleisch AF; Lin PD; Nichols AR; Oken E; Hivert MF
Environ Health Perspect; 2023 Dec; 131(12):127002. PubMed ID: 38054701
[TBL] [Abstract][Full Text] [Related]
9. Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial.
Cardenas A; Gold DR; Hauser R; Kleinman KP; Hivert MF; Calafat AM; Ye X; Webster TF; Horton ES; Oken E
Environ Health Perspect; 2017 Oct; 125(10):107001. PubMed ID: 28974480
[TBL] [Abstract][Full Text] [Related]
10. Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Body Composition From Mid-Childhood to Early Adolescence.
Janis JA; Rifas-Shiman SL; Seshasayee SM; Sagiv S; Calafat AM; Gold DR; Coull BA; Rosen CJ; Oken E; Fleisch AF
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3760-e3770. PubMed ID: 33740056
[TBL] [Abstract][Full Text] [Related]
11. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
[TBL] [Abstract][Full Text] [Related]
12. Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.
Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Romaguera D; Fernández-Barrés S; Santa-Marina L; Basterretxea M; Schettgen T; Valvi D; Vioque J; Sunyer J; Vrijheid M
Environ Health Perspect; 2017 Sep; 125(9):097018. PubMed ID: 28934720
[TBL] [Abstract][Full Text] [Related]
13. Association of diet with per- and polyfluoroalkyl substances in plasma and human milk in the New Hampshire Birth Cohort Study.
Wang Y; Gui J; Howe CG; Emond JA; Criswell RL; Gallagher LG; Huset CA; Peterson LA; Botelho JC; Calafat AM; Christensen B; Karagas MR; Romano ME
Sci Total Environ; 2024 Jul; 933():173157. PubMed ID: 38740209
[TBL] [Abstract][Full Text] [Related]
14. Early-Life Exposure to Perfluoroalkyl Substances and Childhood Metabolic Function.
Fleisch AF; Rifas-Shiman SL; Mora AM; Calafat AM; Ye X; Luttmann-Gibson H; Gillman MW; Oken E; Sagiv SK
Environ Health Perspect; 2017 Mar; 125(3):481-487. PubMed ID: 27586368
[TBL] [Abstract][Full Text] [Related]
15. Associations of per- and polyfluoroalkyl substances with maternal early second trimester sex-steroid hormones.
Pacyga DC; Papandonatos GD; Rosas L; Whalen J; Smith S; Park JS; Gardiner JC; Braun JM; Schantz SL; Strakovsky RS
Int J Hyg Environ Health; 2024 Jun; 259():114380. PubMed ID: 38657330
[TBL] [Abstract][Full Text] [Related]
16. Prenatal perfluoroalkyl substances and newborn anogenital distance in a Canadian cohort.
Arbuckle TE; MacPherson S; Foster WG; Sathyanarayana S; Fisher M; Monnier P; Lanphear B; Muckle G; Fraser WD
Reprod Toxicol; 2020 Jun; 94():31-39. PubMed ID: 32283250
[TBL] [Abstract][Full Text] [Related]
17. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
[TBL] [Abstract][Full Text] [Related]
18. Isomers of per- and polyfluoroalkyl substances and uric acid in adults: Isomers of C8 Health Project in China.
Zeng XW; Lodge CJ; Dharmage SC; Bloom MS; Yu Y; Yang M; Chu C; Li QQ; Hu LW; Liu KK; Yang BY; Dong GH
Environ Int; 2019 Dec; 133(Pt A):105160. PubMed ID: 31518937
[TBL] [Abstract][Full Text] [Related]
19. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
[TBL] [Abstract][Full Text] [Related]
20. Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA).
Preston EV; Webster TF; Oken E; Claus Henn B; McClean MD; Rifas-Shiman SL; Pearce EN; Braverman LE; Calafat AM; Ye X; Sagiv SK
Environ Health Perspect; 2018 Feb; 126(2):027013. PubMed ID: 29488882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
